James Sapp, PA
Physician Assistant · Fredericksburg, VANPI 1013647882
Payments from drug & device makers
Across 202 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$537
- Lilly USA, LLC$450
- AbbVie$421
- Novo Nordisk$364
- AstraZeneca$243
- Lundbeck LLC$191
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,475100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 38 | $537 |
| Lilly USA, LLC | 25 | $450 |
| AbbVie | 30 | $421 |
| Novo Nordisk | 18 | $364 |
| AstraZeneca | 13 | $243 |
| Lundbeck LLC | 10 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $184 |
| GSK | 7 | $109 |
| Pfizer | 6 | $107 |
| Amgen | 4 | $79 |
| Novartis | 4 | $78 |
| Bayer | 4 | $69 |
| Exact Sciences | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 1 | $65 |
| Corium, LLC | 2 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $49 |
| Boehringer Ingelheim | 2 | $49 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Merck | 2 | $28 |
| Boston Scientific | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Medicomp Inc | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Edwards Lifesciences | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$117
How this compares
$3,475 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $63,750 |
| FarxigaDapagliflozin Propanediol | 59 | $61,323 |
| TrulicityDulaglutide | 26 | $40,679 |
| JardianceEmpagliflozin | 27 | $31,418 |
| OzempicSemaglutide | 21 | $31,062 |
| JanuviaSitagliptin Phosphate | 24 | $25,899 |
| XareltoRivaroxaban | 11 | $13,271 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,164 |
| Rosuvastatin Calcium | 336 | $4,890 |
| Levothyroxine Sodium | 302 | $3,449 |
| Atorvastatin Calcium | 325 | $2,994 |
| Pantoprazole Sodium | 143 | $2,372 |
| Potassium Chloride | 64 | $2,276 |
| SynthroidLevothyroxine Sodium | 42 | $2,222 |
| Escitalopram Oxalate | 126 | $2,168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $107 | $63,75058 claims |
| AstraZenecaFarxiga | $243 | $61,32359 claims |
| Lilly USA, LLCTrulicity | $450 | $40,67926 claims |
| Boehringer IngelheimJardiance | $49 | $31,41827 claims |
| Novo NordiskOzempic | $364 | $31,06221 claims |
| MerckJanuvia | $28 | $25,89924 claims |
| GSKTrelegy Ellipta | $109 | $9,16411 claims |
| AbbVieSynthroid | $421 | $2,22242 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Fredericksburg
- Jalal AlghabraFredericksburg$119K
- Leah WallerFredericksburg$18K
- Kaitlin GilbertFredericksburg$13K
- Denise HamiltonFredericksburg$12K
- Monica SpellmanFredericksburg$12K
- John DalessandroSalem$160K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.